NASDAQ: PGEN
Precigen Inc Stock Ownership - Who owns Precigen?

Insider buying vs selling

Have Precigen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randal J. KirkDirector2025-03-1357,471$1.74
$100.00kBuy
Cesar L. AlvarezDirector2025-03-1335,919$1.74
$62.50kBuy
Nancy H. AgeeDirector2025-03-1332,471$1.74
$56.50kBuy
Steven FrankDirector2025-03-1328,735$1.74
$50.00kBuy
Vinita D. GuptaDirector2025-03-1336,206$1.74
$63.00kBuy
Fred HassanDirector2025-03-1336,206$1.74
$63.00kBuy
Jeffrey B. KindlerDirector2025-03-1339,655$1.74
$69.00kBuy
James S. TurleyDirector2025-03-1335,919$1.74
$62.50kBuy
Helen SabzevariPresident and CEO2025-01-29286,967$1.30
$373.06kSell
Phil TennantChief Commercial Officer2025-01-299,441$1.30
$12.27kSell

1 of 2

PGEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PGEN insiders and whales buy or sell their stock.

PGEN Shareholders

What type of owners hold Precigen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk81.71%240,270,361$372.42MInsider
Trading Sa Ares7.02%20,647,152$32.00MInsider
Patient Capital Management LLC6.08%17,881,246$27.72MInstitution
Adage Capital Partners GP LLC3.70%10,865,405$16.84MInstitution
Blackrock Inc3.53%10,376,643$16.08MInstitution
Vanguard Group Inc2.83%8,330,491$12.91MInstitution
Iridian Asset Management LLC1.78%5,241,922$8.12MInstitution
Geode Capital Management LLC1.12%3,299,851$5.11MInstitution
State Street Corp1.01%2,973,967$4.61MInstitution
Helen Sabzevari0.94%2,759,109$4.28MInsider

1 of 3

PGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PGEN21.73%78.27%Net BuyingNet Buying
PRTC0.14%0.00%
ABVX47.14%0.00%
EYPT27.24%72.76%Net BuyingNet Selling
CGEM62.12%37.88%Net BuyingNet Selling

Precigen Stock Ownership FAQ

Who owns Precigen?

Precigen (NASDAQ: PGEN) is owned by 25.76% institutional shareholders, 92.78% Precigen insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Precigen shareholder, owning 240.27M shares representing 81.71% of the company. Randal J. Kirk's Precigen shares are currently valued at $370.02M.

If you're new to stock investing, here's how to buy Precigen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.